| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/24/2006 | EP1322383B1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 05/24/2006 | EP1252183B1 Method for reducing the immunogenicity of staphylokinase by elimination of t-cell epitopes |
| 05/24/2006 | EP1212410B1 Dna encoding the human serine protease eos |
| 05/24/2006 | EP1141305B1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 05/24/2006 | EP1071443B1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | EP1009419B1 Method for identifying modified recombinant Graminae pollen allergens |
| 05/24/2006 | EP0907733B1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | EP0872488B1 MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME |
| 05/24/2006 | CN1777687A Methods of producing influenza vaccine compositions |
| 05/24/2006 | CN1777673A Treatment of IgA1 deposition diseases |
| 05/24/2006 | CN1777622A Modulation of the poliovirus receptor function |
| 05/24/2006 | CN1777621A Antibodies against human il-21 receptor and applications therefor |
| 05/24/2006 | CN1777448A Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry |
| 05/24/2006 | CN1777446A A medicament for the two-step perioperative therapy of solid tumours |
| 05/24/2006 | CN1777444A Compositions and methods for the therapy of inflammatory bowel disease |
| 05/24/2006 | CN1777443A Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 05/24/2006 | CN1777442A Modified live vaccines comprising BHV-1(IBR) and/or BVDV for pregnant and nursing cattles |
| 05/24/2006 | CN1777441A Rapid serological test for paratuberculosis using fluorescence polarization technology |
| 05/24/2006 | CN1777437A Biologically active native biomatrix composition |
| 05/24/2006 | CN1775947A Recombinant adenovirus capable of expressing tomour specific apoptosis peptide, and its preparing method and use |
| 05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
| 05/24/2006 | CN1775809A Bt CrylA antibody, and its preparing method and special antigen and use |
| 05/24/2006 | CN1775808A Anti CD19 engineered antibody for target conjugated lymphocyte, leuco cyte and its use |
| 05/24/2006 | CN1775804A UreG protein, and its preparing method and sue |
| 05/24/2006 | CN1775802A Human papillomavirus immunogenic polypeptide, and its preparing method and use |
| 05/24/2006 | CN1775287A SARS influenza bivalent combined vaccine and its preparing process |
| 05/23/2006 | US7049431 Antisense antibacterial cell division composition and method |
| 05/23/2006 | US7049419 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 05/23/2006 | US7049412 Genetic engineered nucleic acids codes these enzymes; therapy for bone disorders; monoclonal antibodies |
| 05/23/2006 | US7049411 Human anti-factor IX/IXa antibodies |
| 05/23/2006 | US7049408 Preferential polypeptide; for use in the diagnosis and treatment of arthritis |
| 05/23/2006 | US7049407 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049302 A saponin possessing immune adjuvant activity, derived from Quillaja saponaria; an immunostimulatory oligonucleotide cotaining an unmethylated CpG dinucleotide,wherein the immunostimulatory oligonucleotide is not a part of a DNA vaccine vector |
| 05/23/2006 | US7049290 Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon |
| 05/23/2006 | US7049098 Detecting preferential polypeptide in sample; generate expression vector containing preferential protein, express vector, detect preferential polypeptide in sample |
| 05/23/2006 | US7049063 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 05/23/2006 | US7048935 Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
| 05/23/2006 | US7048931 polypeptide with prostate-specific proteins, immunogenic portions or a T cell that is specific for cells expressing such a protein |
| 05/23/2006 | US7048930 Expression of core-glycosylated HCV envelope proteins in yeast |
| 05/23/2006 | US7048929 approximates conformational discontinuous epitopes of a primate lentivirus envelope protein, modifications of the structure has enhanced stability, raises a greater range of antibodies to conserved epitopes, and/or has enhanced immunogenicity for broadly neutralizing epitopes. |
| 05/23/2006 | US7048928 Inhibitor of histamine synthesis, especially of of histidine decarboxylase such as tritoqualine; allergen, e.g., cysteine protease |
| 05/23/2006 | US7048927 treating a cardiovascular disease, especially preventing restenosis in a blood vessel which may occur following a cardiovascular procedure, |
| 05/23/2006 | US7048926 Methods of agonizing and antagonizing FabK |
| 05/23/2006 | US7048925 A polyethyleneimine or polylysine copolymerized polyurea containing multiple ether groups when complexed with polynucleotides form useful transfection reagents |
| 05/23/2006 | US7048924 Combination antiviral and interleukin-2 therapy for HIV infection |
| 05/23/2006 | US7048923 Antibodies to mitogenic oxygenases |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2263921C Oral delayed immediate release formulation and method of preparation therefor |
| 05/23/2006 | CA2227792C Polymeric drug formulations |
| 05/23/2006 | CA2201865C Laminin chains: diagnostic and therapeutic use |
| 05/23/2006 | CA2071974C Vaccine compositions for fish |
| 05/18/2006 | WO2006053110A2 Ovr110 antibody compositions and methods of use |
| 05/18/2006 | WO2006052991A2 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 05/18/2006 | WO2006052900A2 Targeted innate immunity |
| 05/18/2006 | WO2006052820A2 Human immunodeficiency virus vaccine |
| 05/18/2006 | WO2006052773A2 Treatments for demyelinating immune mediated diseases |
| 05/18/2006 | WO2006052668A2 Induction of antigen specific immunologic tolerance |
| 05/18/2006 | WO2006052660A2 Il-7 receptor blockade to suppress immunity |
| 05/18/2006 | WO2006052654A2 Compositions and methods for the treatment of immune mediated diseases |
| 05/18/2006 | WO2006052641A2 Antibody induced cell membrane wounding |
| 05/18/2006 | WO2006052591A2 Anti-properdin antibodies, and methods for making and using same |
| 05/18/2006 | WO2006051984A1 Method of suppressing metastasis of cancer cells and medicinal composition to be used therefor |
| 05/18/2006 | WO2006051946A1 Novel polypeptide having protease inhibitory activity |
| 05/18/2006 | WO2006051396A1 Mutant porcine reproductive and respiratory syndrome virus |
| 05/18/2006 | WO2006051091A1 Compositions against sars-coronavirus and uses thereof |
| 05/18/2006 | WO2006050949A2 Superagonistic anti-cd28 antibody |
| 05/18/2006 | WO2006050729A2 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine |
| 05/18/2006 | WO2006050667A1 MONOCLONAL ANTIBODIES AGAINST APOPTOSIS-RELATED ACETYLCHOLINESTERASE (AR-AChE) AND USE THEREOF |
| 05/18/2006 | WO2006050571A1 Chlamydia antigens and uses thereof |
| 05/18/2006 | WO2006035311A3 Group a streptococcus crge protein |
| 05/18/2006 | WO2006033675A3 Bacillus anthracis spore specific antobodies |
| 05/18/2006 | WO2006020071A3 Vaccines against aids comprising cmv/r-nucleic acid constructs |
| 05/18/2006 | WO2006015297A3 Methods of treating type i diabetes by blocking vegf-mediated activity |
| 05/18/2006 | WO2006002642A3 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 05/18/2006 | WO2005120561A3 Vaccine against infection by a yersinia species |
| 05/18/2006 | WO2005120559A3 Charge gradient inhibition of trypanosoma cruzi and other parasite’s invasive action |
| 05/18/2006 | WO2005118840A3 Diagnostics and therapeutics for diseases associated with kallikrein 10 (klk10) |
| 05/18/2006 | WO2005117941A3 Methods and compositions for the treatment of polycystic diseases |
| 05/18/2006 | WO2005115456A3 METHODS OF MODULATING THE REPRODUCTIVE ENDOCRINE SYSTEM BY MODULATION OF TNFαACTIVITY |
| 05/18/2006 | WO2005113587A3 Gene products expressed differentially in tumors and use thereof |
| 05/18/2006 | WO2005099776A3 Steroid sparing agents and methods of using same |
| 05/18/2006 | WO2005097086A3 Use of 5,10-methylene tetrahydrofolate for the treatment of cancer |
| 05/18/2006 | WO2005079489A3 Method of treating cancer and identifying novel anti-ancer compounds |
| 05/18/2006 | WO2005060995A3 Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 05/18/2006 | WO2005012407A3 Polymer encapsulation of adenoviruses |
| 05/18/2006 | WO2004110355A3 Compositions and methods including a recombinant human mab that promotes cns remyelination |
| 05/18/2006 | WO2004006837A3 Mesothelin vaccines and model systems |
| 05/18/2006 | US20060106204 Bifunctional energy-reversible acyl-compositions |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106196 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105994 Treatment of prostate cancer |
| 05/18/2006 | US20060105982 Non-invasive gene targeting to ocular cells |
| 05/18/2006 | US20060105978 Dose forms |
| 05/18/2006 | US20060105451 Genetically engineered P30 antigen improved antigen cocktail, and uses thereof |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |